Related topics for further reading
Antiangiogenic therapy is a treatment for kidney cancer that works by blocking the growth of blood vessels that feed the tumour. Tumours need blood vessels to grow and spread, so by stopping these blood vessels from forming, the therapy helps slow down or stop the cancer.
Antiangiogenic therapy is also known as targeted therapy because it focuses on specific parts of cancer cells or the blood vessels that feed them. Unlike regular chemotherapy, which affects both healthy and cancer cells, targeted therapy only attacks the cancer cells.
This chapter contains general information about antiangiogenic therapy for kidney cancer. It is not a substitute for professional medical advice or treatment. Always consult your doctor or healthcare provider for guidance on your individual medical situation.
Last updated: May 2025